Wang S - Search Results

1

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).

Yang Y, Pan J, Wang H, Zhao Y, Qu S, Chen N, Chen X, Sun Y, He X, Hu C, Lin L, Yu Q, Wang S, Wang G, Lei F, Wen J, Yang K, Lin Z, Guo Y, Chen S, Huang X, Wu Y, Liang L, Chen C, Bai F, Ma X, Zhang Y, Leaw S, Zhang L, Fang W. Yang Y, et al. Among authors: wang h, wang g, wang s. Cancer Cell. 2023 Jun 12;41(6):1061-1072.e4. doi: 10.1016/j.ccell.2023.04.014. Epub 2023 May 18. Cancer Cell. 2023. PMID: 37207654 Free article. Clinical Trial.

2

[High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].

Xu F, Zhang L, Xiang XJ, Wang ZQ, Zhou ZM, Wang SY. Xu F, et al. Ai Zheng. 2006 Sep;25(9):1120-2. Ai Zheng. 2006. PMID: 16965653 Chinese.

3

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J. Chen L, et al. Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7. Lancet Oncol. 2012. PMID: 22154591 Clinical Trial.

4

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.

Peng PJ, Ou XQ, Chen ZB, Liao H, Peng YL, Wang SY, Zhang HY, Lin Z. Peng PJ, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):323-8. doi: 10.1007/s00280-013-2203-0. Epub 2013 Jun 1. Cancer Chemother Pharmacol. 2013. PMID: 23728706 Clinical Trial.

5

Significant prognostic impact of chemoradiotherapy-induced hemoglobin decrease on treatment outcomes of nasopharyngeal carcinoma.

Liang XX, Li Q, Su Z, Lan XW, Ouyang PY, Mao YP, Shi DB, Deng WG, Cheng ZB, Wang SY, Xie FY. Liang XX, et al. J Cancer. 2015 Apr 2;6(6):502-10. doi: 10.7150/jca.11403. eCollection 2015. J Cancer. 2015. PMID: 26000040 Free PMC article.

6

Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment.

Xue C, Hong S, Li N, Feng W, Jia J, Peng J, Lin D, Cao X, Wang S, Zhang W, Zhang H, Dong W, Zhang L. Xue C, et al. Among authors: wang s. Sci Rep. 2015 Jul 28;5:10648. doi: 10.1038/srep10648. Sci Rep. 2015. PMID: 26216071 Free PMC article. Clinical Trial.

7

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.

Peng PJ, Lv BJ, Tang C, Liao H, Lin Z, Liu YM, Wang ZH, Wang SY, Cheng ZB. Peng PJ, et al. Drug Des Devel Ther. 2015 Dec 10;9:6401-5. doi: 10.2147/DDDT.S95946. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26677316 Free PMC article. Clinical Trial.

8

Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.

Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F. Liang Z, et al. Among authors: wang s. Cancer Chemother Pharmacol. 2016 Mar;77(3):643-51. doi: 10.1007/s00280-016-2971-4. Epub 2016 Jan 30. Cancer Chemother Pharmacol. 2016. PMID: 26831498 Clinical Trial.

9

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.

Peng P, Ou X, Liao H, Liu Y, Wang S, Cheng Z, Lin Z. Peng P, et al. Among authors: wang s. Ther Adv Med Oncol. 2016 May;8(3):153-9. doi: 10.1177/1758834016637592. Epub 2016 Mar 11. Ther Adv Med Oncol. 2016. PMID: 27239233 Free PMC article.

10

Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J. Chen L, et al. Eur J Cancer. 2017 Apr;75:150-158. doi: 10.1016/j.ejca.2017.01.002. Epub 2017 Feb 22. Eur J Cancer. 2017. PMID: 28235726 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109,293 results

Search Page